You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LGMD-2C/R5

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

LGMD2E/R4, LGMD2D/R3, and LGMD2C/R5, = 4 Years of Age, Who Are

Recruiting
  • Limb-girdle Muscular Dystrophy
    • Phoenix, Arizona
    • +14 more
    Aug 23, 2022

    Long-Term Development of Muscular Dystrophy Outcome Assessments

    Not yet recruiting
    • LGMD1A
    • +33 more
      • Richmond, Virginia
        Virginia Commonwealth University
      Aug 3, 2023

      LGMD2C Trial (ATA-200)

      Not yet recruiting
      • LGMD2C
      • ATA-200
      • (no location specified)
      Aug 1, 2023

      Trial Readiness and Endpoint Assessment in LGMD R1

      Not yet recruiting
      • Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
      • +3 more
        • Richmond, Virginia
          Virginia Commonwealth University
        Jan 10, 2023

        Limb Girdle Muscular Dystrophy Trial in Columbus (SRP-6004)

        Enrolling by invitation
        • Limb Girdle Muscular Dystrophy
        • SRP-6004
        • Columbus, Ohio
          Nationwide Children's Hospital
        Jun 7, 2023

        Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2, LGMD2I Trial (LION-101 dose level 1, LION-101 dose level

        Not yet recruiting
        • Limb Girdle Muscular Dystrophy
        • +8 more
        • LION-101 dose level 1
        • +2 more
        • (no location specified)
        Feb 17, 2022

        Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency, Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy

        Recruiting
        • Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency
        • +51 more
          • Lakewood, California
            Congenital Muscle Disease International Registry (www.cmdir.org)
          Aug 3, 2021

          Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

          Not yet recruiting
          • Diabetes Mellitus Type 2 With Proteinuria
          • +12 more
          • Empagliflozin 10 MG
          • +6 more
          • (no location specified)
          Oct 17, 2023

          Brodalumab in Plaque Psoriasis to Understand Impact on Quality

          Recruiting
          • Psoriasis
          • Brodalumab
          • Matched cohort
          • Calgary, Alberta, Canada
          • +33 more
          Oct 8, 2022

          Type 2 Diabetes, Obesity Trial in Worldwide (Tirzepatide, Placebo)

          Not yet recruiting
          • Type 2 Diabetes
          • Obesity
          • Caba, Buenos Aires, Argentina
          • +48 more
          Sep 8, 2023

          Implementation of Personalized Medicine for Optimal Drug Therapy

          Not yet recruiting
          • Nausea With Vomiting Chemotherapy-Induced
          • +2 more
          • Pharmacogenetic testing
          • Drug-Drug interaction analysis
          • London, Ontario, Canada
            Lawson Health Research Institute
          Apr 13, 2023

          Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)

          Not yet recruiting
          • Pneumococcal Vaccines
          • IVT PCV-25 Formulation A
          • +3 more
          • Vancouver, British Columbia, Canada
          • +3 more
          Oct 10, 2023

          Papulopustular Rosacea Trial in Canada (Lotilaner Gel, 2.0%, Vehicle control gel)

          Recruiting
          • Papulopustular Rosacea
          • Lotilaner Gel, 2.0%
          • Vehicle control gel
          • Oakville, Ontario, Canada
          • +4 more
          Apr 20, 2023

          Prostate Cancer Trial in Vancouver, Toronto, Montréal (Survivorship Care Plan)

          Active, not recruiting
          • Prostate Cancer
          • Survivorship Care Plan
          • Vancouver, British Columbia, Canada
          • +2 more
          Nov 14, 2022

          Cystic Fibrosis Pulmonary Exacerbation Trial in Canada (Prednisone, Placebos)

          Recruiting
          • Cystic Fibrosis Pulmonary Exacerbation
          • Calgary, Alberta, Canada
          • +11 more
          Nov 23, 2022

          Psoriasis Trial in Worldwide (Secikinumab)

          Active, not recruiting
          • Psoriasis
          • AdroguĂ©, Buenos Aires, Argentina
          • +80 more
          Oct 14, 2022

          Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in Valhalla (DOC Group B, Pv-COMRAD 1 and 2 Group B, Pv-R-CYM 1 and 2 Group B)

          Recruiting
          • Non-hodgkin Lymphoma
          • Hodgkin Lymphoma
          • DOC Group B
          • +16 more
          • Valhalla, New York
            New York Medical College
          Jun 9, 2022

          Infection Trial in Canada (Fecal Microbiota Transplantation (FMT))

          Suspended
          • Infection
          • Fecal Microbiota Transplantation (FMT)
          • Brampton, Ontario, Canada
          • +12 more
          Nov 1, 2022

          COVID-19 Trial in Canada (Artesunate, Imatinib, Infliximab)

          Recruiting
          • COVID-19
          • Calgary, Alberta, Canada
          • +56 more
          Jan 12, 2023

          Vasovagal Syncope Trial in Winnipeg, Montreal (Metoprolol, Matching Placebo)

          Active, not recruiting
          • Vasovagal Syncope
          • Winnipeg, Manitoba, Canada
          • +1 more
          Nov 1, 2022

          Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)

          Not yet recruiting
          • Non-melanoma Skin Cancer
          • +3 more
          • Calgary, Alberta, Canada
          • +7 more
          Jul 13, 2023

          Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)

          Recruiting
          • Prostate Cancer Metastatic
          • Ablative Radiation Therapy
          • Standard of care
          • Victoria, British Columbia, Canada
          • +14 more
          Nov 14, 2022

          Malaria, Falciparum Trial in Oxford (Matrix M with R78C and/or RH5.1)

          Not yet recruiting
          • Malaria, Falciparum
          • Matrix M with R78C and/or RH5.1
          • Oxford, United Kingdom
            CCVTM, University of Oxford, Churchill Hospital
          May 26, 2022

          Vasovagal Syncope Trial in Canada, Poland, United States (midodrine HCl, matching )

          Active, not recruiting
          • Vasovagal Syncope
          • midodrine hydrochloride
          • matching placebo
          • Minneapolis, Minnesota
          • +16 more
          Nov 1, 2022

          Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

          Suspended
          • Recurrent B-Cell Non-Hodgkin Lymphoma
          • +7 more
          • Philadelphia, Pennsylvania
            Sidney Kimmel Cancer Center at Thomas Jefferson University
          Jan 20, 2023